bell
The current prices are delayed by 15 mins, login to check live prices.
Wockhardt Ltd share price logo

Wockhardt Share Price

(WOCKPHARMA)

₹1325.453.88%

as on 04:01PM, 29 Jan 2025

Overview
News
Financials
Q3 FY24-25 Results
Technicals

Wockhardt Performance

  • Day's Low

    Day's High

    ₹1,276.2
    Day's Price Range
    ₹1,346
  • 52 Week's Low

    52 Week's High

    ₹420
    52-Week Price Range
    ₹1,582.95
1 Month Return-10.12 %
3 Month Return+ 16.04 %
1 Year Return+ 179.18 %
Previous Close₹1,276.00
Open₹1,278.35
Volume2.92L
Upper Circuit-
Lower Circuit-
Market Cap₹20,731.47Cr

Wockhardt Key Statistics

P/E Ratio-64.41
PEG Ratio-4.07
Market Cap₹20,731.47 Cr
P/B Ratio5
EPS-30.65
Dividend Yield0
SectorPharmaceuticals
ROE0

Wockhardt Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹20,731.47 Cr59.18%0.77-₹472 Cr₹2,798 Cr
BUY₹24,827.72 Cr95.74%0.52₹300 Cr₹1,051 Cr
BUY₹14,049.46 Cr13.69%0.57₹72 Cr₹6,702 Cr
NA₹5,258.87 Cr-3.9%0.79-₹388 Cr₹75 Cr
BUY₹13,961.83 Cr41.08%0.68₹218 Cr₹1,296 Cr

About Wockhardt

Wockhardt Ltd. is an Indian pharmaceutical and biotechnology company that is listed on the Indian stock exchange. Founded in the early 1960's, the company has grown to become a recognized leader in the development of quality products and providing healthcare solutions across the world. Wockhardt has a global presence, with research and development facilities in the United States, Europe and India. With an extensive portfolio of products that includes medicines, vaccines, biopharmaceuticals, and health supplements, Wockhardt is committed to providing access to safe and innovative solutions to meet the unique needs of customers and communities. Wockhardt is a growing company with a strong commitment to providing reliable, quality products and services to its customers across the globe.

Share Price: ₹1325.45 per share as on 29 Jan, 2025 04:01 PM
Market Capitalisation: ₹20,731.47Cr as of today
Revenue: ₹809.00Cr as on September 2024 (Q3 24)
Net Profit: ₹-16.00Cr as on September 2024 (Q3 24)
Listing date: 23 Feb, 2000
Chairperson Name: H F Khorakiwala
OrganisationWockhardt
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

What's happening today

  • img

    Today's Timeline - Invalid Date

    06:00 AM

    -

    Wockhardt Ltd shows strong support and potential rebound, aided by positive RSI divergence.

Key events for Wockhardt Ltd

  • Wockhardt Ltd Shows Potential for Rebound - 30 Jan, 2025

    Wockhardt Ltd is experiencing strong support levels and positive RSI divergence, indicating a potential rebound in stock performance. Market participants are optimistic about its recovery.
  • Wockhardt's Zaynich Shows Promise, Stock Surges - 16 Jan, 2025

    Wockhardt's new antibiotic Zaynich demonstrates a 100% cure rate in trials, leading to a 191% stock increase over the past year. Plans for launches in India and globally are set for 2024-2026.
  • Wockhardt's Antibiotics Show Efficacy, Shares Surge - 13 Jan, 2025

    Wockhardt Ltd's shares surged as its antibiotic Zaynich demonstrated over 97% efficacy against drug-resistant infections. The company also anticipates revenue growth from its new drug Miqnaf targeting superbugs.
  • Wockhardt Anticipates Rs 400 Crore Revenue from Miqnaf - 07 Jan, 2025

    Wockhardt Ltd. expects Rs 400 crore revenue from its new antibiotic Miqnaf, targeting community-acquired bacterial pneumonia. The drug will launch in FY26, with significant market potential.
  • Wockhardt Shares Surge on Miqnaf Approval - 03 Jan, 2025

    Wockhardt Ltd's shares rose significantly after the CDSCO approved its antibiotic Miqnaf for treating community-acquired bacterial pneumonia, reaching a new 52-week high. The company anticipates substantial market potential and revenue growth from this new drug.
  • Wockhardt Receives Approval for New Antibiotic Miqnaf - 02 Jan, 2025

    Wockhardt Ltd has received CDSCO approval for Miqnaf (nafithromycin), a new oral antibiotic for community-acquired bacterial pneumonia, enhancing treatment options against antibiotic resistance. The drug offers a three-day treatment regimen and targets multi-drug-resistant pathogens, addressing a significant healthcare challenge in India.

Insights on Wockhardt Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, WOCKPHARMA stock has moved up by 50.1%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.09% to 7.13% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 34.39% to 34.53% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 709.0 Cr → 818.0 Cr (in ₹), with an average increase of 4.6% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.09% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.61% to 6.54% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -14.0 Cr → -22.0 Cr (in ₹), with an average decrease of 57.1% per quarter

Wockhardt Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹753.00Cr (-)₹701.00Cr (↓6.91%)₹700.00Cr (↓0.14%)₹739.00Cr (↑5.57%)₹809.00Cr (↑9.47%)
Net Income-₹73.00Cr (-)-₹86.00Cr (↑17.81%)-₹177.00Cr (↑105.81%)-₹16.00Cr (↓90.96%)-₹16.00Cr (-)
Net Profit Margin-9.69% (-)-12.27% (↑26.63%)-25.29% (↑106.11%)-2.17% (↓91.42%)-1.98% (↓8.76%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,096.00Cr (-)₹6,027.00Cr (↑18.27%)₹4,978.00Cr (↓17.41%)₹5,114.00Cr (↑2.73%)
Total Liabilities₹3,490.00Cr (-)₹3,815.00Cr (↑9.31%)₹3,225.00Cr (↓15.47%)₹3,318.00Cr (↑2.88%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹221.51Cr (-)-₹563.00Cr (↓354.16%)-₹93.00Cr (↓83.48%)₹71.00Cr (↓176.34%)₹188.00Cr (↑164.79%)

Index Inclusions

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Healthcare

₹41,149.54

2.2 (885.32%)

BSE Small-Cap

₹49,050.57

3.28 (1558.09%)

Wockhardt Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
49.09%
0.00
Foreign Institutions
6.54%
-1.08
Mutual Funds
7.13%
0.58
Retail Investors
34.53%
0.40
Others
2.71%
-3.74

Wockhardt Key Indicators

Details2021
Return On Equity %56.52
Details20202021202220232024
Return On Assets %-1.3813.46-4.05-11.23-9.05
Details20202021202220232024
Book Value Per Share (₹)222.32282.82267.29232.92218.12
Details20202021202220232024
Earning Per Share (₹)-3.6157.64-19.38-43.13-30.65

Wockhardt Valuation

Wockhardt in the last 5 years

  • Overview

  • Trends

Lowest (-94.57x)

October 8, 2021

Today (-64.41x)

January 28, 2025

Industry (53.05x)

January 28, 2025

Highest (12.70x)

May 26, 2021

LowHigh

Wockhardt Earnings and Dividends

  • Wockhardt Ltd Earnings Results

    Wockhardt Ltd’s net profit jumped 71.43% since last year same period to ₹-22Cr in the Q2 2024-2025. On a quarterly growth basis, Wockhardt Ltd has generated -57.14% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Wockhardt Ltd Dividends November,2016

    In the quarter ending September 2016, Wockhardt Ltd has declared dividend of ₹10 - translating a dividend yield of 0.75%.

    Read More about Dividends

Wockhardt Technicals Summary

Bearish

Neutral

Bullish

Bearish

Wockhardt Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Wockhardt Ltd

What is Wockhardt Ltd price today?

Wockhardt Ltd share price today stands at ₹1325.45, Open: ₹1278.35, Previous Close: ₹1276, High: ₹1346, Low: ₹1276.2, 52 Week High: ₹1582.95, 52 Week Low: ₹420.

How to Buy Wockhardt Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Wockhardt Ltd shares

Is Wockhardt Ltd listed on NSE?

Wockhardt Ltd is listed on NSE

Is Wockhardt Ltd listed on BSE?

Wockhardt Ltd is listed on BSE

What are today's High and Low prices of Wockhardt Ltd?

  • Today's highest price of Wockhardt Ltd is ₹1346.
  • Today's lowest price of Wockhardt Ltd is ₹1276.2.

What are today's traded volumes of Wockhardt Ltd?

Today's traded volume of Wockhardt Ltd(WOCKPHARMA) is 2.92L.

What is today's market capitalisation of Wockhardt Ltd?

Today's market capitalisation of Wockhardt Ltd(WOCKPHARMA) is ₹20731.47Cr.

What is the 52 Week High and Low Range of Wockhardt Ltd?

Wockhardt Ltd (WOCKPHARMA)
Price
52 Week High
₹1582.95
52 Week Low
₹420

How much percentage Wockhardt Ltd is down from its 52 Week High?

Wockhardt Ltd (WOCKPHARMA) share price is ₹1325.45. It is down -16.27% from its 52 Week High price of ₹1582.95

How much percentage Wockhardt Ltd is up from its 52 Week low?

Wockhardt Ltd (WOCKPHARMA) share price is ₹1325.45. It is up 215.58% from its 52 Week Low price of ₹420

What are the historical returns of Wockhardt Ltd?

Wockhardt Ltd (WOCKPHARMA)
Returns
1 Day Returns
49.45%
1 Month Returns
-10.12%
3 Month Returns
16.04%
1 Year Returns
179.18%

What is the PE ratio of Wockhardt Ltd today?

PE Ratio of Wockhardt Ltd is -64.41

PE ratio = Wockhardt Ltd Market price per share / Wockhardt Ltd Earnings per share